BROOKS DONALD S

Administrateur chez CASI Pharmaceuticals, Inc (DE) · enregistré depuis Jun 19, 2006

Opérations d’initié de BROOKS DONALD S

Transactions enregistrées: 16; depuis Oct 22, 2003

Achats sur le marché: 0

Ventes sur le marché: 0

Sociétés négociées: 1; dernière déclaration Jan 25, 2012

Chiffres calculés à partir des déclarations réglementaires officielles — .

Sociétés où BROOKS DONALD S a négocié

CASI Pharmaceuticals, Inc (DE)16 tx · $50K · Jan 25, 2012

Historique de performance de BROOKS DONALD S

Historique insuffisant pour un historique de performance statistique (moins de 5 achats sur le marché).

Historique des transactions de BROOKS DONALD S

Co-initiés de BROOKS DONALD S

Bair Kenneth WalterCASI Pharmaceuticals, Inc (DE)
Bliss Thomas H JrCASI Pharmaceuticals, Inc (DE)
Bray Mark RCASI Pharmaceuticals, Inc (DE)
Burns James SCASI Pharmaceuticals, Inc (DE)
BUSH DWIGHT LCASI Pharmaceuticals, Inc (DE)
CAMPBELL NEIL JCASI Pharmaceuticals, Inc (DE)
CAPE RONALDCASI Pharmaceuticals, Inc (DE)
CAPITELLI SARA BCASI Pharmaceuticals, Inc (DE)
CELGENE CORP /DE/CASI Pharmaceuticals, Inc (DE)
Chi GeorgeCASI Pharmaceuticals, Inc (DE)
Corrado MarcCASI Pharmaceuticals, Inc (DE)
He Wei-WuCASI Pharmaceuticals, Inc (DE)
Huang JamesCASI Pharmaceuticals, Inc (DE)
HUNTER CEVERA JENNIECASI Pharmaceuticals, Inc (DE)
IDG-Accel China Growth Fund GP III Associates Ltd.CASI Pharmaceuticals, Inc (DE)
JOHNSON JAMES DCASI Pharmaceuticals, Inc (DE)
KLEIN UDOCASI Pharmaceuticals, Inc (DE)
KNIGHT PETER SCASI Pharmaceuticals, Inc (DE)
Lin DongliangCASI Pharmaceuticals, Inc (DE)
Mak Tak W.CASI Pharmaceuticals, Inc (DE)
RANDALL MARK C MCASI Pharmaceuticals, Inc (DE)
Ren KenCASI Pharmaceuticals, Inc (DE)
Ren Ken KeyongCASI Pharmaceuticals, Inc (DE)
SAGLIO DANE RCASI Pharmaceuticals, Inc (DE)
Salisbury Franklin Cary jrCASI Pharmaceuticals, Inc (DE)
SHROTRIYA RAJESH C MDCASI Pharmaceuticals, Inc (DE)
Sidor Carolyn FCASI Pharmaceuticals, Inc (DE)
SPARKLE BYTE LTDCASI Pharmaceuticals, Inc (DE)
Spectrum Pharmaceuticals Cayman, L.P.CASI Pharmaceuticals, Inc (DE)
SPECTRUM PHARMACEUTICALS INCCASI Pharmaceuticals, Inc (DE)
TARNOW MICHAEL MCASI Pharmaceuticals, Inc (DE)
Wealth Strategy Holding LtdCASI Pharmaceuticals, Inc (DE)
Wehmeir-Davis KathyCASI Pharmaceuticals, Inc (DE)

Cette page reprend des déclarations réglementaires publiques.

Société	Déclarée	Type	Qté	Prix	Valeur · USD	Src
CASI Pharmaceuticals, Inc (DE)	Jan 25, 2012	AttributionD (dérivé)	25,000	0.00 USD	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jan 12, 2011	AttributionD (dérivé)	10,000	0.00 USD	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jan 28, 2010	AttributionD (dérivé)	50,000	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Feb 4, 2009	AttributionD (dérivé)	30,000	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Feb 4, 2009	AttributionD (dérivé)	30,000	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 6, 2008	AttributionD (dérivé)	30,000	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 6, 2008	Attribution	39,063	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 18, 2007	Attribution	15,823	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 18, 2007	AttributionD (dérivé)	30,000	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 19, 2006	AttributionD (dérivé)	30,000	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 19, 2006	Attribution	16,025	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jul 29, 2005	AttributionD (dérivé)	30,000	0.00 USD	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jul 29, 2005	Attribution	8,064	0.00 USD	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 18, 2004	AttributionD (dérivé)	30,000	0.00 USD	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 18, 2004	Attribution	11,574	2.16 USD	$25K	SEC
CASI Pharmaceuticals, Inc (DE)	Oct 22, 2003	Attribution	4,553	5.49 USD	$25K	SEC

Société	Déclarée	Type	Qté	Prix	Valeur · USD	Src
CASI Pharmaceuticals, Inc (DE)	Jan 25, 2012	AttributionD (dérivé)	25,000	0.00 USD	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jan 12, 2011	AttributionD (dérivé)	10,000	0.00 USD	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jan 28, 2010	AttributionD (dérivé)	50,000	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Feb 4, 2009	AttributionD (dérivé)	30,000	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Feb 4, 2009	AttributionD (dérivé)	30,000	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 6, 2008	AttributionD (dérivé)	30,000	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 6, 2008	Attribution	39,063	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 18, 2007	Attribution	15,823	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 18, 2007	AttributionD (dérivé)	30,000	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 19, 2006	AttributionD (dérivé)	30,000	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 19, 2006	Attribution	16,025	0.00	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jul 29, 2005	AttributionD (dérivé)	30,000	0.00 USD	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jul 29, 2005	Attribution	8,064	0.00 USD	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 18, 2004	AttributionD (dérivé)	30,000	0.00 USD	—	SEC
CASI Pharmaceuticals, Inc (DE)	Jun 18, 2004	Attribution	11,574	2.16 USD	$25K	SEC
CASI Pharmaceuticals, Inc (DE)	Oct 22, 2003	Attribution	4,553	5.49 USD	$25K	SEC